Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Yn: BMJ Open, Cyfrol 5, Rhif 5, 27.05.2015.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey
AU - Rose, P.W.
AU - Rubin, G.
AU - Perera-Salazar, R.
AU - Almberg, S.S.
AU - Barisic, A.
AU - Dawes, M.
AU - Grunfeld, E.
AU - Hart, N.
AU - Neal, R.D.
AU - Pirotta, M.
AU - Sisler, J.
AU - Konrad, G.
AU - Toftegaard, B.S.
AU - Thulesius, H.
AU - Vedsted, P.
AU - Young, J.
AU - Hamilton, W.
AU - The ICBP Module 3 Working Group., [No Value]
PY - 2015/5/27
Y1 - 2015/5/27
N2 - The International Cancer Benchmarking Partnership (ICBP) is a collaboration between 6 countries and 12 jurisdictions with similar primary care-led health services. This study investigates primary care physician (PCP) behaviour and systems that may contribute to the timeliness of investigating for cancer and subsequently, international survival differences
AB - The International Cancer Benchmarking Partnership (ICBP) is a collaboration between 6 countries and 12 jurisdictions with similar primary care-led health services. This study investigates primary care physician (PCP) behaviour and systems that may contribute to the timeliness of investigating for cancer and subsequently, international survival differences
U2 - 10.1136/bmjopen-2014-007212
DO - 10.1136/bmjopen-2014-007212
M3 - Article
VL - 5
JO - BMJ Open
JF - BMJ Open
SN - 2044-6055
IS - 5
ER -